— Know what they know.
Not Investment Advice

ENOV

Enovis Corporation
1W: -5.0% 1M: -2.1% 3M: -20.2% YTD: -17.6% 1Y: -44.6% 3Y: -58.7% 5Y: -74.5%
$21.85
-0.72 (-3.19%)
After Hours: $23.50 (+1.65, +7.55%)
NYSE · Industrials · Industrial - Machinery · $1.3B · Alpha Radar Neutral · Power 54
Smart Money Score
Bullish 75
Insider+$0.2M
Congress
ETF Holdings
Key Statistics
Market Cap$1.3B
52W Range21-40.7
Volume1,576,630
Avg Volume1,084,442
Beta1.60
Dividend
Analyst Ratings
10 Buy 3 Hold 0 Sell
Consensus Buy
Company Info
CEODamien McDonald
Employees7,367
SectorIndustrials
IndustryIndustrial - Machinery
IPO Date2008-05-08
Websiteenovis.com
2711 Centerville Road
Wilmington, DE 19808
US
302 252 9190
About Enovis Corporation

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Recent Insider Trades

NameTypeSharesPriceDate
Engert Oliver P-Purchase 1,000 $23.74 2026-03-13
Engert Oliver P-Purchase 1,000 $23.93 2026-03-10
Engert Oliver P-Purchase 1,000 $23.39 2026-03-09
KLECKNER JOHN A-Award 14,925 2026-03-09
ROSS TERRY D A-Award 36,247 2026-03-09

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms